Prokinetic therapy reduces aspiration pneumonia in tube-fed patients with severe developmental disabilities

American Journal on Mental Retardation

Volumn 112, Issue 6, 2007, Pages 467-471

  Pareek, Namita ^a   Williams, John ^b   Hanna, Deborah ^b   Johnson, William D ^a   Minocha, Anil ^a   Abell, Thomas L ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b Arlington Developmental Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; PROKINETIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; ASPIRATION PNEUMONIA; CEREBRAL PALSY; CLINICAL ARTICLE; DEVELOPMENTAL DISORDER; FEMALE; HOSPITAL ADMISSION; HUMAN; JEJUNOSTOMY TUBE; MALE; MEDICAL RECORD REVIEW; MENTAL DEFICIENCY; PATIENT MONITORING; QUADRIPLEGIA; RETROSPECTIVE STUDY; RISK REDUCTION; SPINE MALFORMATION; STOMACH TUBE; TUBE FEEDING;

CHILD, PRESCHOOL; CISAPRIDE; DEVELOPMENTAL DISABILITIES; ENTERAL NUTRITION; FEMALE; HUMANS; INFANT; MALE; PNEUMONIA, ASPIRATION; SEROTONIN AGONISTS; SEVERITY OF ILLNESS INDEX;

EID: 37349036470     PISSN: 08958017     EISSN: None     Source Type: Journal    
DOI: 10.1352/0895-8017(2007)112[467:PTRAPI]2.0.CO;2     Document Type: Article

References (19)

1. Abstracts. (1986). First International Cisapride Investigators' meeting. Digestion, 34, 137-160.
2. Corazziari, E., Bontempo, I., & Anzini, F. (1989). Effects of Cisapride on distal esophageal motility in humans. Digestive Diseases and Sciences, 34, 1600-1605.
3. Delegge, M. H. (2002). Aspiration pneumonia: Incidence, mortality, and at-risk populations. Journal of Parenteral and Enteral Nutrition, 26(6), S19-23.
4. Kazi, N., & Mobarhan, S. (1996). Enteral feeding associated gastroesophageal reflux and aspiration pneumonia: A review. Nutrition Reviews, 54, 324-328.
5. Larson, S. A., Lakin, K. C., Anderson, L., Kwak, N., Lee, J. H., & Anderson, D. (2001). Prevalence of mental retardation and developmental disabilities: Estimates from the 1994/1995 National Health Interview Survey Disability Supplements. American Journal on Mental Retardation, 106, 231-252.
6. Madsen, J. L. (1990). Effects of Cisapride on gastrointestinal transit in healthy humans. Digestive Diseases and Sciences, 35, 1500-1504.
7. Metheny, N. A. (2002). Risk factors for aspiration. Journal of Parenteral and Enteral Nutrition, 26(6), S26-31.
8. Physician's desk reference (53rd ed.). (1999). Cisapride product information. Montvale, NJ: Medical Economics Comp..
9. Pick, N., McDonald, A., Bennett, N., Litsche, M., Dietsche, L., Legerwood, R., Spurgas, R., & LaForce, F. M. (1996). Pulmonary aspiration in a long-term care setting: Clinical and laboratory observations and an analysis of risk factors. Journal of American Geriatrics Society, 44, 763-768.
10. Pneumatikos, J., Koulouras, B., Frangides, C., Goe, D., & Nakos, G (1999). Cisapride decreases gastric content aspiration in mechanically ventilated patients. Critical Care, 3, 39-43.
11. Rajendran, S. K., Reier, J. R., Bauman, W., Zhang, R. L., Gordon, S. K., & Korsten, M. A. (1992). Gastrointestinal transit after spinal cord injury: Effect of Cisapride. American Journal of Gastroentrology, 87, 1614-1617.
12. Reyntjens, A., Verlinden, M., De Coster, R., Janisch, H. D., Smout, A., De Cree, J., Leempoels, J., & Verhaegen, H. (1984). Clinical pharmacological evidence for Cisapride lack of antidopaminergic or direct cholinergic properties. Current Therapeutic Research, 36, 1045-1051.
13. Richards, R. D., Valenzuela, G. A., Davenport, K. G., Fisher, K. L. K., & McCallum, R. W. (1993). Objective and subjective results of a randomized, double blind, placebo-controlled trial using Cisapride to treat gastroparesis. Digestive Diseases and Sciences, 38, 811-816.
14. Sanko, J. S. (2004). Aspiration assessment and prevention in critically ill enterally fed patients. Gastroenterology Nutrition, 27, 279-285.
15. Sartori, S., Trevisani, L., Nielsen, I., Gilli, G., Donati, D., & Malacarne, P. (1994). Prevention of aspiration pneumonia during long-term feeding by percutaneous endoscopic gastrostomy: Might Cisapride play any role? An open pilot study. Support Care Cancer, 2, 188-190.
16. Schiller, L. R. (1996). Upper gastrointestinal motility disorders and respiratory symptoms. American Journal of Health and Systemic Pharmacology, 53(15), S13-26.
17. Strauss, D., Anderson, T. W., Shavelle, R., Sheridan, F., & Trenkle, S. (1998). Causes of death of persons with developmental disabilities: Comparison of institutional and community residents. Mental Retardation, 36, 386-391.
18. Van Nueten, J. M. (1985). Cholinergic versus antidopaminergic properties of prokinetic substituted benzamides with gastrointestinal prokinetic activity. Gastroentrology, 88, 1623.
19. Wysowski, D. K., Corken, A., Gallo-Torres, H., Talarico, L., & Rodriguez, E. M. (2001). Post-marketing reports of QJ prolongation and ventricular arrhythmia in association with Cisapride and Food and Drug Administration regulatory actions. American Journal of Gastroentrology, 96, 1698-1703.